Integrating 16S rRNA Sequencing, Microflora Metabolism, and Network Pharmacology to Investigate the Mechanism of SBL in Alleviating HDM-Induced Allergic Rhinitis
Open Access
- 8 August 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8655
Abstract
Allergic rhinitis (AR) is a series of allergic reactions to allergens in the nasal mucosa and is one of the most common allergic diseases that affect both children and adults. Shi-Bi-Lin (SBL) is the modified formula of Cang Er Zi San (CEZS), a traditional Chinese herbal formula used for treating AR. Our study aims to elucidate the anti-inflammatory effects and mechanisms of SBL in house dust mite-induced AR by regulating gut microflora metabolism. In vivo studies showed that nasal allergies and the infiltration of inflammatory cells in the nasal epithelium were significantly suppressed by SBL. Moreover, SBL restored the impaired nasal epithelial barrier function with an increased tight junction protein expression and reduced the endothelial nitric oxide synthase (eNOS). Interestingly, SBL significantly reconstituted the abundance and composition of gut microbiota in AR mice; it increased the relative abundance of potentially beneficial genera and decreased the relative abundance of harmful genera. SBL also restored immune-related metabolisms, which were significantly increased and correlated with suppressing inflammatory cytokines. Furthermore, a network analysis and molecular docking indicated IL-6 was a possible target drug candidate for the SBL treatment. SBL dramatically reduced the IL-6 level in the nasal lavage fluid (NALF), suppressing the IL-6 downstream Erk1/2 and AKT/PI3K signaling pathways. In conclusion, our study integrates 16S rRNA sequencing, microflora metabolism, and network pharmacology to explain the immune mechanism of SBL in alleviating HDM-induced allergic rhinitis.Keywords
Funding Information
- State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants (The Chinese University of Hong Kong/CUHK) from Innovation and Technology Commission
- Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine
- Ming Lai Foundation
This publication has 52 references indexed in Scilit:
- Gleditsia sinensis Lam. aqueous extract attenuates nasal inflammation in allergic rhinitis by inhibiting MUC5AC production through suppression of the STAT3/STAT6 pathwayBiomedicine & Pharmacotherapy, 2023
- Cyanidin and delphinidin restore colon physiology in high fat diet-fed mice: Involvement of TLR-4 and redox-regulated signalingFree Radical Biology and Medicine, 2022
- Role of gut microbiota in identification of novel TCM-derived active metabolitesProtein & Cell, 2020
- House Dust Mite-Induced Allergic Rhinitis: Is Prevention an Option?Current Treatment Options in Allergy, 2019
- Gallic acid alleviates nasal inflammation via activation of Th1 and inhibition of Th2 and Th17 in a mouse model of allergic rhinitisInternational Immunopharmacology, 2019
- Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancerApoptosis, 2018
- Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicineChemico-Biological Interactions, 2017
- Lipoxin A4 protects against lipopolysaccharide-induced sepsis by promoting innate response activator B cells generationInternational Immunopharmacology, 2016
- Epithelium: At the interface of innate and adaptive immune responsesJournal of Allergy and Clinical Immunology, 2007
- A Novel Effect of Nivalenol (NIV) on the Immune Response2005